» Articles » PMID: 12200067

Pathogen-specific Regulatory T Cells Provoke a Shift in the Th1/Th2 Paradigm in Immunity to Infectious Diseases

Overview
Journal Trends Immunol
Date 2002 Aug 30
PMID 12200067
Citations 82
Authors
Affiliations
Soon will be listed here.
Abstract

Current dogma suggests that immunity to infection is controlled by distinct type 1 (Th1) and type 2 (Th2) subpopulations of T cells discriminated on the basis of cytokine secretion and function. However, a further subtype of T cells, with immunosuppressive function and cytokine profiles distinct from either Th1 or Th2 T cells, termed regulatory T (Tr) cells has been described. Although considered to have a role in the maintenance of self-tolerance, recent studies suggest that Tr cells can be induced against bacterial, viral and parasite antigens in vivo and might prevent infection-induced immunopathology or prolong pathogen persistence by suppressing protective Th1 responses. These observations have significant implications for our understanding of the role of T cells in immunity to infectious diseases and for the development of new therapies for immune-mediated disorders.

Citing Articles

Sending a Message: Use of mRNA Vaccines to Target the Tumor Immune Microenvironment.

Ramirez F, Zambrano A, Hennis R, Holland N, Lakshmanaswamy R, Chacon J Vaccines (Basel). 2023; 11(9).

PMID: 37766141 PMC: 10534833. DOI: 10.3390/vaccines11091465.


The evolution and heterogeneity of neutrophils in cancers: origins, subsets, functions, orchestrations and clinical applications.

Liu S, Wu W, Du Y, Yin H, Chen Q, Yu W Mol Cancer. 2023; 22(1):148.

PMID: 37679744 PMC: 10483725. DOI: 10.1186/s12943-023-01843-6.


Dietary Plant Polysaccharides for Cancer Prevention: Role of Immune Cells and Gut Microbiota, Challenges and Perspectives.

Wang A, Liu Y, Zeng S, Liu Y, Li W, Wu D Nutrients. 2023; 15(13).

PMID: 37447345 PMC: 10347129. DOI: 10.3390/nu15133019.


Identification of a Five Immune Term Signature for Prognosis and Therapy Options (Immunotherapy versus Targeted Therapy) for Patients with Hepatocellular Carcinoma.

Bin X, Luo Z, Wang J, Zhou S Comput Math Methods Med. 2023; 2023:8958962.

PMID: 36785674 PMC: 9918845. DOI: 10.1155/2023/8958962.


Natural blood plasma-based hydrogels as tumor vaccines delivery systems to enhance biomimetic recruitment of antigen presenting cells for tumor immunotherapy.

Huang L, Peng S, Liu Z, Zhang J, Liu N, Lin J Mater Today Bio. 2022; 17:100497.

PMID: 36420056 PMC: 9677221. DOI: 10.1016/j.mtbio.2022.100497.